Navigation Links
CBI's Interactive Response Technologies for Clinical Trials - the Only IVR/IWR Event of Its Kind - Will Be in Philadelphia on November 14-15, 2011
Date:10/25/2011

BOSTON, Oct. 25, 2011 /PRNewswire/ -- Eighteen leading industry speakers will present at Interactive Response Technologies for Clinical Trials on November 14-15, 2011 in Philadelphia. Nearly 100 IRT professionals convene for this interactive and educational exploration of the major shift taking place in clinical trials - using IVR/IWR to collect and analyze clinical trial data.

Many bio/pharmaceutical companies look to mitigate delays, minimize costs and increase overall operational efficiencies through their IVR/IWR systems. Moreover, companies are striving to identify preferred vendors. During the session, "Assess the Operational Value of Establishing Preferred IRT Vendors," Sunny Xie, Senior Director, Process Optimization, Clinical Development Operations & Biometrics and Kate Chapman, Associate Director, IRT Services, both of Shire Pharmaceuticals, uncover an effective model for managing this vendor relationship. Five real-world case studies round out the educational opportunities.

Networking is available both days with such industry leaders as Biogen Idec, Merck Sharpe & Dohme, Boehringer Ingelheim, Abbott, Millennium, Takeda, Johnson & Johnson, Novartis, Allergen, and many more.

For more information and details on how to register for this event, visit http://www.cbinet.com/IVR.

Contact:  

Cathy Rossi-Cecere
Phone number: 339-298-2128
Email address: cathy@cbinet.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. Cool new tools let public contribute to massive interactive online biodiversity encyclopedia
2. Scientists put interactive flu tracking at publics fingertips
3. GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits
4. GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits
5. Elsevier and Legacy Interactive partner to launch iPhone app
6. Millisecond brain signals predict response to fast-acting antidepressant
7. RNA molecules, delivery system improve vaccine responses, effectiveness
8. Response to immune protein determines pathology of multiple sclerosis
9. Forsyth scientists trigger cancer-like response from embryonic stem cells
10. NIAID funds studies of how SARS and bird flu evade antiviral responses
11. How eating fruit and vegetables can improve cancer patients response to chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2016)... CLARA, Calif. , Nov. 14, 2016 ... the biometric identification market, Frost & Sullivan ... Frost & Sullivan Award for Visionary Innovation ... player in the biometric identification market by ... multi-modal verification solution for instant, seamless, and ...
(Date:6/22/2016)... 2016  The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
(Date:6/22/2016)... On Monday, the Department of Homeland Security ... solutions for the Biometric Exit Program. The Request for ... (CBP), explains that CBP intends to add biometrics to ... United States , in order to deter visa ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... and CAMBRIDGE, Mass. ... , Dec. 4, 2016 SystemOne, ... connected diagnostics software platforms for the developing world, ... "Anywhere. Care.™" a reality with its portable and ... entered into a development and license agreement to ...
(Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... demonstrating the value of DNA microarray comparative genomic hybridization (array CGH) for ... Breast Cancer Symposium. Using molecular test results from tumors with previously documented ...
(Date:12/2/2016)... ... , ... DrugDev believes the only way to achieve real change ... three tenets were on display at the 2nd Annual DrugDev User Summit (hosted by ... and site organizations to discuss innovation and the future of clinical research. , ...
Breaking Biology Technology: